165 related articles for article (PubMed ID: 2962889)
1. Teicoplanin, a new antibiotic effective against gram-positive bacterial infections of the skin and soft tissues.
Bochud-Gabellon I; Regamey C
Dermatologica; 1988; 176(1):29-38. PubMed ID: 2962889
[TBL] [Abstract][Full Text] [Related]
2. Teicoplanin in the treatment of skin and soft tissue infections.
Turpin PJ; Taylor GP; Logan MN; Wood MJ
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():117-22. PubMed ID: 2965123
[TBL] [Abstract][Full Text] [Related]
3. Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
Campoli-Richards DM; Brogden RN; Faulds D
Drugs; 1990 Sep; 40(3):449-86. PubMed ID: 2146108
[TBL] [Abstract][Full Text] [Related]
4. Intravenous or intramuscular teicoplanin once daily for skin and soft-tissue infections.
Edelstein HE; Oster SE; Chirurgi VA; Karp RA; Cassano KB; McCabe RE
DICP; 1991 Sep; 25(9):914-8. PubMed ID: 1835223
[TBL] [Abstract][Full Text] [Related]
5. Teicoplanin: a new glycopeptide antibiotic complex.
Babul N; Pasko M
Drug Intell Clin Pharm; 1988 Mar; 22(3):218-26. PubMed ID: 2966729
[TBL] [Abstract][Full Text] [Related]
6. Teicoplanin in the treatment of skin and soft tissue infections: results of a multicentre study.
Lang E; Földes M; Marghescu S
Infection; 1991; 19(3):190-4. PubMed ID: 1832418
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and safety of teicoplanin in the treatment of gram-positive infections.
Kempf P; Pompetzki H; Oppermann A; Wittenberger R; Siebert J; Fell JJ; Dieterich HA
Infection; 1989; 17(3):177-81. PubMed ID: 2525529
[TBL] [Abstract][Full Text] [Related]
8. Teicoplanin in the treatment of infections by staphylococci, Clostridium difficile and other gram-positive bacteria.
de Lalla F; Santoro D; Rinaldi E; Suter F; Cruciani M; Guaglianone MH; Rizzardini G; Pellegata G
J Antimicrob Chemother; 1989 Jan; 23(1):131-42. PubMed ID: 2526109
[TBL] [Abstract][Full Text] [Related]
9. Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: an open study.
Pauluzzi S; Del Favero A; Menichetti F; Baratta E; Moretti VM; Di Filippo P; Pasticci MB; Guerciolini R; Patoia L; Frongillo RF
J Antimicrob Chemother; 1987 Sep; 20(3):431-8. PubMed ID: 2960643
[TBL] [Abstract][Full Text] [Related]
10. Modern management of cutaneous bacterial infections.
Duncan WC
Postgrad Med; 1972 Nov; 52(5):96-101. PubMed ID: 5080958
[No Abstract] [Full Text] [Related]
11. Treatment of bone and soft tissue infections with teicoplanin.
Marone P; Concia E; Andreoni M; Suter F; Cruciani M
J Antimicrob Chemother; 1990 Mar; 25(3):435-9. PubMed ID: 2140111
[TBL] [Abstract][Full Text] [Related]
12. Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts.
Van der Auwera P; Aoun M; Meunier F
Antimicrob Agents Chemother; 1991 Mar; 35(3):451-7. PubMed ID: 1828134
[TBL] [Abstract][Full Text] [Related]
13. Antibiotics and skin infections: when to use local or systemic measures.
Bremner DA
Drugs; 1977 Jan; 13(1):52-6. PubMed ID: 832615
[No Abstract] [Full Text] [Related]
14. Infections due to gram-positive organisms in children: possible role for teicoplanin.
Dagan R; Einhorn M; Howard CB; Williams AH
J Antimicrob Chemother; 1991 Apr; 27 Suppl B():37-41. PubMed ID: 1829075
[TBL] [Abstract][Full Text] [Related]
15. Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin.
Greenberg RN
Antimicrob Agents Chemother; 1990 Dec; 34(12):2392-7. PubMed ID: 2150908
[TBL] [Abstract][Full Text] [Related]
16. [Teicoplanin and Gram-positive coccus infections. Results of a multicenter study on 66 cases].
Dureux JB; Canton P; Chavanet P; Chippaux C; Dupeyron JP; Estavoyer JM; Giorgi C; Jaeger A; Jehl F; Kazmierzack A
Pathol Biol (Paris); 1987 May; 35(5):511-5. PubMed ID: 2956564
[TBL] [Abstract][Full Text] [Related]
17. A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.
Guskey MT; Tsuji BT
Pharmacotherapy; 2010 Jan; 30(1):80-94. PubMed ID: 20030476
[TBL] [Abstract][Full Text] [Related]
18. Teicoplanin--a new agent for gram-positive bacterial infections.
Eggleston M; Ofosu J
Infect Control Hosp Epidemiol; 1988 May; 9(5):209-11. PubMed ID: 2967322
[No Abstract] [Full Text] [Related]
19. [Microbiological-clinical study on the efficacy of a new antibiotic: teicoplanin].
Martinetto P; Gariglio M; Malcangi A; Cavallo GP
G Batteriol Virol Immunol; 1985; 78(1-6):86-94. PubMed ID: 2943627
[TBL] [Abstract][Full Text] [Related]
20. An open study of teicoplanin in the treatment of gram-positive infections.
Nathwani D; Reid TM; Gould IM; Golder D; Smith CC; Douglas JG
J Chemother; 1991 Oct; 3(5):315-20. PubMed ID: 1839742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]